Mutation significance (MutSig) analysis confirmed enrichment in CRC driver gene mutations of APC, TP53, KRAS, PIK3CA, SOX9, SMAD4, and FBXW7 in 83%, 73%, 37%, 20%, 14%, 14% and 12% of liver metastases, respectively (Fig. 3c, Supplementary Fig. 13, and Supplementary Data 7). Here, KRAS is linked to colorectal carcinoma.